HARRISBURG, PA | August 16, 2022
Today the American Lung Association in Pennsylvania announced the start of its 2023-2024 research awards and grants cycle. The organization is now accepting research grant applications from researchers here in Pennsylvania and across the nation with the potential to improve prevention, detection and treatment options for all lung diseases including lung cancer.
In Pennsylvania, the American Lung Association has previously funded researchers such as University of Pittsburgh researchers Amanda Poholek, PhD, awarded the Innovation Award for her project “Learning Protein’s Role in Allergic Asthma Could Lead to New Treatments” and Maryam Sharifi-Sanjani, PhD, awarded the Catalyst Award for her project, “Assisting Heart Function in Pulmonary Hypertension.” And in Philadelphia, Fox Chase Cancer Center researchers: Alfonso Bellacosa, MD, MHS, awarded the Lung Cancer Discovery Award for his project “Improving Response Rates of Immunotherapy for Lung Cancer” and Johnathan Whetstine, PhD received the Lung Cancer Discovery Award for his research project, “Enzyme Could Help Predict Effectiveness of Lung Cancer Chemotherapy.”
“Here in Pennsylvania, we have wonderful research institutions and leading-edge researchers,” said Deborah Brown, Chief Mission Officer for the American Lung Association. “The Lung Association is committed to supporting the best scientific minds to help develop solutions to alleviate the burden of lung disease. We encourage innovative researchers in Pennsylvania to apply for these grants.”
Research projects funded by the Lung Association are carefully selected through rigorous scientific review and awardees represent the investigation of a wide range of complex issues to reduce the suffering and burden of lung disease.
Below is a list of currently available research funding opportunities:
• COVID-19 & Respiratory Virus Research Award: $100,000 per year for up to two years
This award is intended to support investigators who have the ability to advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants have evidence of ongoing excellence and productivity in a related field.
• Lung Cancer Discovery Award: $100,000 per year for up to two years
Intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. A Letter of Intent (LOI) is required for this award.
• Allergic Respiratory Diseases Award: $75,000 per year for up to two years
A long-standing joint effort between the American Lung Association and the American Academy of Allergy, Asthma & Immunology to encourage and support early-stage investigators with a primary faculty appointment in an allergy/immunology division or section, to conduct research into advancing the understanding of allergic respiratory disease.
• Innovation Award: $75,000 per year for up to two years
This award will support promising independent investigators who are leveraging their existing body of work to conduct basic science, behavioral, clinical or translational research for lung health.
• Catalyst Award: $50,000 per year for up to two years
This award champions the next generation of scientists who are ascending toward independence by supporting mentored investigators who are conducting basic science, behavioral, clinical or translational research into lung health.
• Public Policy Research Award: $50,000 per year for up to two years
This mechanism is designed to help stimulate and inform important public policy debates around healthy air and lung disease. This award supports research on and evaluation of existing public policy and programs, as well as projects that inject innovative ideas into public policies impacting lung health.
• Dalsemer Award: $50,000 per year for up to two years
This is a mentored award meant to provide seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
For more information about the active research funding opportunities, visit Lung.org/awards.
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. To support the work of the American Lung Association, find a local event at Lung.org/events.
We urgently need your help against Big Tobacco!
Saving lives starts by ending the sale of menthol cigarettes and all flavored cigars. Join us in urging the White House to finalize these rules before the end of the year.